If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTNT.L Regulatory News (TNT)

  • There is currently no data for TNT

Form 8.3 - Offeree - Updated

29 Sep 2023 10:46

RNS Number : 1849O
Tintra PLC
29 September 2023
 

FORM 8 (OPD)

 

This is an amendment to the announcement dated 21 September 2023 (RNS number 2825N)

 

Section 3a is amended as follows: The holding of the Tintra Trust is reduced from 5,053,611 ordinary shares to 4,853,611 ordinary shares and from 28.50% to 27.37%

 

Amendment to section 3b

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Tintra plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Tintra plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

19 September 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

 

(a) Beneficial holdings of the Directors of Tintra plc (including their close relatives) in its ordinary shares of 1p each

 

Name

Number of ordinary shares held

% of voting rights

The Tintra Trust1

4,853,611

27.37

Time Machine Capital 2 Limited2

636,475

3.59

Dr Joe Lyske

108,002

0.60

Roger Matthews

104,407

0.58

Kathy Cox

30,000

0.16

John Cripps

15,000

0.08

Total

5,947,495

33.51

 

1- A trust, the beneficiary of which is Tintra Holdings Limited, a company incorporated in the Ras Al Khaimah International Corporate Centre, UAE, which in turn is controlled by Richard Shearer, a director of Tintra PLC.

2- Dr Joe Lyske, a director of Tintra PLC, is a Person of Significant Control of Time Machine Capital 2 Ltd.

 

(b) Beneficial holdings of others being identified as being in concert with the Offeree (including their close relatives) in its ordinary shares of 1p each

 

Name

Number of ordinary shares held

% of voting rights

Andrew Flitcroft1

627,237

3.53

The Tintra Foundation2

200,000

1.12

Total

827,237

4.65

 

1- Andrew Flitcroft is the Company Secretary of Tintra PLC.

2- The Tintra Foundation is an independently managed foundation based in Switzerland which receives support from Tintra PLC as part of its ESG strategy.

 

(c) Rights to subscribe for ordinary shares of Tintra plc (including their close relatives) in its ordinary shares of 1p each

 

Name

Date of grant

Exercise price (p)

Expiry date

Number outstanding

Warrants

Time Machine Capital 2 Limited1

24 Nov 2021

52.5

24 Nov 2026

636,475

Conversion Loan Notes

The Tintra Trust2

13 Aug 2021 to 8 Nov 2022

10

13 Aug 2024 to 8 Nov 2025

2,441,770

Total

3,078,245

 

1- Dr Joe Lyske, a director of Tintra PLC, is a Person of Significant Control of Time Machine Capital 2 Ltd.

2- A trust, the beneficiary of which is Tintra Holdings Limited, a company incorporated in the Ras Al Khaimah International Corporate Centre, UAE, which in turn is controlled by Richard Shearer, a director of Tintra PLC.

 

 

 

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

28 September 2023

Contact name:

Andrew Flitcroft, Company Secretary

Telephone number:

020 3795 0421

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPPUGCBUPWUBB
Date   Source Headline
21st Apr 20226:15 pmRNSIssue of Ordinary Shares Under Funding Round
19th Apr 20227:15 amRNSGranting of Mauritius Payment Services License
1st Apr 20224:20 pmRNSIssue of Equity
1st Apr 20229:04 amRNSUpdate on proposed sale of Lottery & Funding Round
29th Mar 202212:30 pmRNSUpdate on UK Authorisation Strategy
21st Mar 20227:45 amRNSFurther Strategic Investment Under Funding Round
17th Mar 20227:00 amRNSWorld’s first Web 3.0 bank to power metaverse
8th Mar 202210:30 amRNSAppointment of Independent Non-Executive Director
7th Mar 202212:00 pmRNSThe way to AML success?
7th Mar 20227:00 amRNSFurther Strategic Investment Under Funding Round
25th Feb 20227:00 amRNSUpdate re Lottery Business
10th Feb 20224:00 pmRNSHolding in Company & PCA Dealing
4th Feb 202210:30 amRNSArtificial Intelligence's Role in Banking 3.0
3rd Feb 20227:00 amRNSAppointment of Independent Non-Executive Director
1st Feb 20222:29 pmRNSTotal Voting Rights
27th Jan 202210:03 amRNSHolding(s) in Company & Update re Lottery Business
25th Jan 20223:30 pmRNSIssue of Equity
24th Jan 20227:00 amRNSFurther re. Strategic Investment
17th Jan 202210:45 amRNSUpdate re Funding Round
10th Jan 20222:30 pmRNSPDMR Dealing & Holding in Company
10th Jan 20229:00 amRNSStrategic Investment Under Funding Round
31st Dec 202112:00 pmRNSTotal Voting Rights
13th Dec 20217:00 amRNSAppointment of Chief Financial Officer
8th Dec 202111:00 amRNSProvision of Guarantees to St Daniel House Ltd
26th Nov 20212:45 pmRNSFurther re Fundraising
24th Nov 20217:45 amRNSEntry into AI Joint Venture
10th Nov 20212:37 pmRNSDisposal of interest in Soccer Business
4th Nov 202112:00 pmRNSResult of Meeting & Strategy Update
29th Oct 20212:30 pmRNSPress Release on OTCQB Venture Market Admission
29th Oct 20217:00 amRNSHalf-year Report for the 6 Months to 31 July 2021
28th Oct 20217:00 amRNSTrading on OTCQB Venture Market Starting Today
26th Oct 20219:30 amRNSApplication for a Puerto Rico IFE Licence
26th Oct 20217:01 amRNSRevised Arrangements with MDC Nominees Ltd
21st Oct 20217:00 amRNSHeads of terms for sale of the lottery business
13th Oct 20213:30 pmRNSUpdate on AI Joint Venture
8th Oct 20213:30 pmRNSNotice of GM
1st Oct 20217:00 amRNSBusiness Update, Board Changes, TVR & PDMR Dealing
24th Sep 20219:05 amRNSSecond Price Monitoring Extn
24th Sep 20219:00 amRNSPrice Monitoring Extension
24th Sep 20217:30 amRNSConversion of Loan Stock & Strategic Investment
1st Sep 20217:00 amRNSHolding(s) in Company & Total Voting Rights
23rd Aug 20217:00 amRNSDirector/PDMR Shareholding
20th Aug 202111:30 amRNSResult of Adjourned AGM
13th Aug 20213:39 pmRNSConversion of Securities
13th Aug 202111:30 amRNSConversion of Securities
13th Aug 20217:00 amRNSExercise of Option & Issue of Convertible Stock
3rd Aug 20217:00 amRNSChange of Name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.